Navigation Links
Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon

response offered by the 1200-microgram dose on a two-week administration schedule," said Dr. Stump.

    Albuferon 1200-mcg Monthly (Albuferon 1200 Q4w)


    -- ITT analysis shows that 50.9% of patients in the Albuferon 1200 Q4w

       treatment group achieved SVR, vs. 57.9% for Pegasys administered every

       week.

    -- In heavier patients (>75 kg) who were treatment-adherent, 61.0% of

       those in the Albuferon 1200 Q4w treatment group achieved SVR, versus

       53.3% for Pegasys administered once every week.

    -- Among all treatment-adherent patients in the Albuferon 1200 Q4w

       treatment group, 62.0% achieved SVR, versus 66.7% for Pegasys.

    -- The rate of discontinuations due to adverse events was 12.1% in the

       Albuferon 1200 Q4w treatment group, vs. 6.1% in the Pegasys group.

    -- The number of patients experiencing severe hematologic adverse events

       was significantly lower in the Albuferon 1200 Q4w treatment group

       (10.3%, vs. 23.7% for Pegasys, p=0.006).

"We are encouraged that more than half of the patients achieved sustained virologic response in the treatment group receiving Albuferon 1200-mcg once every month," said Dr. Stump. "These data, along with emerging Phase 2 data for a monthly 1500-mcg dose, provide an excellent rationale for the study that we and our collaborator, Novartis, are currently planning to evaluate higher doses of Albuferon administered monthly."

The top-line final Phase 2b results include data through Week 24 following completion of 48 weeks of therapy. The open-label, multi-center, active- controlled, dose-ranging trial enrolled and randomized 458 patients with genotype 1 chronic hepatitis C. Patients were randomized into four treatment groups, three of which received subcutaneously administered Albuferon (900 mcg every two weeks, 1200 mcg every two weeks, and 1200 mcg every four weeks). The fourth treatment group served as the active control group and recei
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Testing for Human Papillomavirus
2. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
3. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
4. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
5. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
6. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
7. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
8. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
9. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
10. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
(Date:7/31/2014)... 31, 2014 Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... initiated the development of its lead molecule, Anatabine Citrate, ... has selected Quotient Clinical, The Translational Pharmaceutics Company, based ... to run its early development programs. The ... by the end of the third quarter with the ...
(Date:7/31/2014)... 2014  A substantial share of pharmacy and ... therapies are included in formularies—say patient support resources ... new Manhattan Research study, Taking the Pulse® ... that P&T committee members in hospitals, managed care ... set a high bar for these programs, requiring ...
(Date:7/31/2014)... 31, 2014 Hovione today announced that ... has successfully passed a pre-approval inspection by the US Food ... by the FDA Consumer Safety Officer, Ms. Britanny Terhar ... st July and concluded on the 25 th . ... principles and guidelines of Good Manufacturing Practices (GMP) and no ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 2Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 3Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 4Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 2Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 3Successful FDA Inspection at Hovione's API Manufacturing Plant in Cork, Ireland 2
... ... Reportlinker.com announces that a new market research ... India Dental Devices Investment Opportunities, Analysis and Forecasts ... , Description ...
... , , BOSTON, Nov. 23 ... image and information management solutions, today announced that it will ... Society of North America (RSNA) annual meeting from November 29 ... the North Hall in booth #7124. , (Logo: ...
Cached Medicine Technology:Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 2Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 3Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 4Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 5Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 6Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 7Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 8Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 9Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 10Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 11Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 12Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 13Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015 14AMICAS' Enterprise Imaging Solutions Highlighted at RSNA 2009 2AMICAS' Enterprise Imaging Solutions Highlighted at RSNA 2009 3
(Date:8/1/2014)... (PRWEB) August 01, 2014 Narrow ... health plans and employers effective options to trim ... networks argue that they can enhance formulary compliance ... fees. Consultants report that nearly all PBMs now ... requests for proposals. The Aug. 12 webinar ...
(Date:8/1/2014)... Fitness is something most people can add to a ... block to biking ten or more miles, adding daily exercise ... the year. The Forbes Living talk show is ... special guests, tips to get started and cool products to ... air on most popular cable television networks. , About ...
(Date:8/1/2014)... CA (PRWEB) August 01, 2014 ... advancing gynecologic endoscopic surgery, is pleased to announce ... in the United States and Europe, which strongly ... available to surgeons an endoscopic dry lab for ... of their endoscopic surgery skills. , Endoscopy is ...
(Date:8/1/2014)... retailer Disposable Medical Express has announced that they will ... of Tranquility incontinence care products. The website carries Tranquility’s ... personal care products. , “We know how hard ... products that you love,” a said company representative. “So ... shouldn't have to compromise because of cost.” , ...
(Date:8/1/2014)... NY (PRWEB) August 01, 2014 Millions ... that affects the legs and in some cases the ... estimates state that about 17 million women in the ... of women dealing with the pain, embarrassment and discomfort ... and even some physicians are unaware that this is a ...
Breaking Medicine News(10 mins):Health News:Atlantic Information Services Webinar to Offer Health Plan, Employer Strategies for Implementing Narrow Pharma Networks 2Health News:Forbes Living to Air Fitness Forward Series 2Health News:AAGL Announces It Has Joined With Other Medical Societies to Encourage Hospitals Teaching Endoscopic Surgery to Establish Simulator Labs for Training 2Health News:Disposable Medical Express Offering Low Price Guarantee On Tranquility Products 2Health News:Lipedema Centers Works With Insurers To Gain Coverage For Lipedema Treatment 2
... Inc. (OTC Bulletin Board: CARN) today said the ... be webcast live from the Kennedy I Room ... Healthcare Conference at New York City,s Palace Hotel ... The presentation will cover DelSite,s three key ...
... CAMBRIDGE, Mass., Nov. 5 Abt Associates has ... Office of Planning, Research,and Evaluation within the U.S. ... and Families (ACF) to lead a major evaluation,of ... and former recipients of Temporary Assistance for Needy ...
... Care Awareness Week, WASHINGTON, Nov. 5 ... coverage for long-term care expenses,according to new survey ... The survey found that many Baby Boomers have ... have not thought about,long-term care insurance. (Logo: ...
... Relaxation in large, sound- and light-proof tanks with ... stress-related pain. This has been shown by Sven-ke ... with a dissertation from Karlstad University in Sweden. ... have indicated: sleep was improved, patients felt more ...
... may be more accurate than existing biological signposts ... into advanced forms of the disease. , ... edition of the International Journal of Cancer, the ... prevent patients from unnecessarily undergoing aggressive cancer treatments. ...
... /Xinhua-PRNewswire-FirstCall/ -- China Holdings, Inc.,(OTC Bulletin Board: ... its subsidiaries engage in multiple China-focused business ... real,estate, and pharmaceuticals, announced today the Company ... exclusive rights to develop and construct,the 2nd ...
Cached Medicine News:Health News:Carrington's DelSite Presentation at Rodman & Renshaw Conference to be Webcast Live on November 7th 2Health News:Abt Associates to Lead Major Evaluation of Programs Aimed at Promoting Self-Sufficiency for Disadvantaged Families 2Health News:New Survey Finds One in Four Baby Boomers Erroneously Believe They Have Coverage for Long-Term Care Expenses 2Health News:New Survey Finds One in Four Baby Boomers Erroneously Believe They Have Coverage for Long-Term Care Expenses 3Health News:Floating effective for stress and pain 2Health News:Biomarker may be an early predictor of advanced breast cancer 2Health News:China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energy Pipeline 2Health News:China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energy Pipeline 3Health News:China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energy Pipeline 4Health News:China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energy Pipeline 5Health News:China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energy Pipeline 6Health News:China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energy Pipeline 7Health News:China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energy Pipeline 8
CUSA DISSECTRON PORTABLE UNIT is an ultrasonic surgical aspirator for the fragmentation and emulsification of tissue available only outside the United States....
The Nevyas Drape Support is the simple and inexpensive way to establish a zone of comfort for your patients during ophthalmic surgery which requires draping over the nose and mouth. Packaged in sets ...
This is a 2.5x focusing Galilean telescope with a range from 70cm to infinity. Ideal for use at sporting events, as well as for a wide range of hobbies....
... us to the practical limit of ... often a 'last resort' option for ... The illuminated housing ensures a constant ... battery handle by a lightweight cord ...
Medicine Products: